These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34064193)

  • 1. Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.
    Wang X; Zhou N; Liu T; Jia X; Ye T; Chen K; Li G
    Mar Drugs; 2021 May; 19(6):. PubMed ID: 34064193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic Vaccinia Virus Expressing
    Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li G; Cheng J; Mei S; Wu T; Ye T
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Vaccinia Virus Harboring
    Jiang R; Qiu Y; Zhang X; Zhou N; Jia X; Chen K; Zhou Y; Ye T; Li G
    Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer.
    Zhang G; Wang Q; Yuan R; Zhang Y; Chen K; Yu J; Ye T; Jia X; Zhou Y; Li G; Chen K
    Biochem Biophys Res Commun; 2024 Oct; 730():150355. PubMed ID: 38996784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS Induced by
    Zhang Y; Zhu Y; Jiang G; Chen K; Zhang G; Chen K; Ye T; Zhou Y; Li G
    Mar Drugs; 2024 Jun; 22(7):. PubMed ID: 39057416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Vaccinia Virus Carrying
    Zheng X; Xu W; Ying Q; Ni J; Jia X; Zhou Y; Ye T; Li G; Chen K
    Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354990
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Li G; Mei S; Cheng J; Wu T; Luo J
    Mar Drugs; 2018 Apr; 16(5):. PubMed ID: 29701680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic Vaccinia Virus Harboring
    Ni J; Feng H; Xu X; Liu T; Ye T; Chen K; Li G
    Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677432
    [No Abstract]   [Full Text] [Related]  

  • 12. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.
    Fu X; Rivera A; Tao L; Zhang X
    Mol Ther; 2012 Oct; 20(10):1871-81. PubMed ID: 22692498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL-24 gene in liver cancer cells.
    Wang C; Li Q; Xiao B; Fang H; Huang B; Huang F; Wang Y
    J Clin Lab Anal; 2021 Mar; 35(3):e23677. PubMed ID: 33274495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy.
    Shi Z; Liu B; Huang C; Xie W; Cen Y; Chen L; Liang M
    Biochem Biophys Res Commun; 2021 Jun; 559():176-182. PubMed ID: 33945995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
    Tysome JR; Wang P; Alusi G; Briat A; Gangeswaran R; Wang J; Bhakta V; Fodor I; Lemoine NR; Wang Y
    Hum Gene Ther; 2011 Sep; 22(9):1101-8. PubMed ID: 21361787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.
    Adelfinger M; Gentschev I; Grimm de Guibert J; Weibel S; Langbein-Laugwitz J; Härtl B; Murua Escobar H; Nolte I; Chen NG; Aguilar RJ; Yu YA; Zhang Q; Frentzen A; Szalay AA
    PLoS One; 2014; 9(8):e104337. PubMed ID: 25093734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AVL-armed oncolytic vaccinia virus promotes viral replication and boosts antitumor immunity via increasing ROS levels in pancreatic cancer.
    Yu J; An N; Zhu J; Zhu B; Zhang G; Chen K; Zhou Y; Ye T; Li G
    Mol Ther Oncol; 2024 Dec; 32(4):200878. PubMed ID: 39431173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.